Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Fei Jia, Juan Hong, Ping-Hua Sun, Jian-Xin Chen & Wei-Min Chen. (2013) Facile Synthesis of the Neuraminidase Inhibitor Peramivir. Synthetic Communications 43:19, pages 2641-2647.
Read now
Read now
Pooran Chand. (2005) Recent advances in the discovery and synthesis of neuraminidase inhibitors. Expert Opinion on Therapeutic Patents 15:8, pages 1009-1025.
Read now
Read now
Douglas M Fleming. (2003) Zanamivir in the treatment of influenza. Expert Opinion on Pharmacotherapy 4:5, pages 799-805.
Read now
Read now
Donald F Smee & Robert W Sidwell. (2002) Peramivir (BCX-1812, RWJ-270201): potential new therapy for influenza. Expert Opinion on Investigational Drugs 11:6, pages 859-869.
Read now
Read now
Articles from other publishers (31)
Fangzhao Chen, Luoping Yang, Yingna Huang, Yun Chen, Huiting Sang, Wenjun Duan & Jie Yang. (2020) Isocorilagin, isolated from Canarium album (Lour.) Raeusch, as a potent neuraminidase inhibitor against influenza A virus. Biochemical and Biophysical Research Communications 523:1, pages 183-189.
Crossref
Crossref
Kotey, Lukosaityte, Quaye, Ampofo, Awandare & Iqbal. (2019) Current and Novel Approaches in Influenza Management. Vaccines 7:2, pages 53.
Crossref
Crossref
Elham Moasser, Alireza Moasser & Hassan Zaraket. (2019) Incidence of antiviral drug resistance markers among human influenza A viruses in the Eastern Mediterranean Region, 2005–2016. Infection, Genetics and Evolution 67, pages 60-66.
Crossref
Crossref
Anna Luganini, Maria E. Terlizzi, Gianluca Catucci, Gianfranco Gilardi, Massimo E. Maffei & Giorgio Gribaudo. (2018) The Cranberry Extract Oximacro® Exerts in vitro Virucidal Activity Against Influenza Virus by Interfering With Hemagglutinin. Frontiers in Microbiology 9.
Crossref
Crossref
Erhard van der Vries & Michael G. Ison. 2017. Antimicrobial Drug Resistance. Antimicrobial Drug Resistance
1165
1183
.
Emanuela Erba & Concetta La Rosa. (2016) A novel synthetic approach to the racemic Neuraminidase inhibitor Peramivir. Tetrahedron 72:49, pages 7975-7981.
Crossref
Crossref
Jiraphorn Phanich, Thanyada Rungrotmongkol, Daniel Sindhikara, Saree Phongphanphanee, Norio Yoshida, Fumio Hirata, Nawee Kungwan & Supot Hannongbua. (2016) A 3D-RISM/RISM study of the oseltamivir binding efficiency with the wild-type and resistance-associated mutant forms of the viral influenza B neuraminidase. Protein Science 25:1, pages 147-158.
Crossref
Crossref
Susanne C. Duwe, Marianne Wedde, Patricia Birkner & Brunhilde Schweiger. (2011) Genotypic and phenotypic resistance of pandemic A/H1N1 influenza viruses circulating in Germany. Antiviral Research 89:1, pages 115-118.
Crossref
Crossref
Elena A. Govorkova & Jonathan A. McCullers. 2013. Swine Influenza. Swine Influenza
273
300
.
Natalia A. Ilyushina, Jon P. Seiler, Jerold E. Rehg, Robert G. Webster & Elena A. Govorkova. (2010) Effect of Neuraminidase Inhibitor–Resistant Mutations on Pathogenicity of Clade 2.2 A/Turkey/15/06 (H5N1) Influenza Virus in Ferrets. PLoS Pathogens 6:5, pages e1000933.
Crossref
Crossref
Yuji Matsuya, Nozomi Suzuki, Shin-ya Kobayashi, Tatsuro Miyahara, Hiroshi Ochiai & Hideo Nemoto. (2010) Synthesis and anti-influenza virus activity of dihydrofuran-fused perhydrophenanthrenes with a benzyloxy-type side-chain. Bioorganic & Medicinal Chemistry 18:4, pages 1477-1481.
Crossref
Crossref
S. Yongkiettrakul, K. Boonyapakron, A. Jongkaewwattana, A. Wanitchang, U. Leartsakulpanich, P. Chitnumsub, L. Eurwilaichitr & Y. Yuthavong. (2009) Avian influenza A/H5N1 neuraminidase expressed in yeast with a functional head domain. Journal of Virological Methods 156:1-2, pages 44-51.
Crossref
Crossref
Frederick G. Hayden. 2009. Antimicrobial Drug Resistance. Antimicrobial Drug Resistance
1011
1033
.
Maturos Malaisree, Thanyada Rungrotmongkol, Panita Decha, Pathumwadee Intharathep, Ornjira Aruksakunwong & Supot Hannongbua. (2008) Understanding of known drug-target interactions in the catalytic pocket of neuraminidase subtype N1. Proteins: Structure, Function, and Bioinformatics 71:4, pages 1908-1918.
Crossref
Crossref
Nicole Ritz & Nigel Curtis. 2008. Hot Topics in Infection and Immunity in Children IV. Hot Topics in Infection and Immunity in Children IV
164
184
.
Tasneem Islam & Mark von Itzstein. 2007. Advances in Carbohydrate Chemistry and Biochemistry Volume 61. Advances in Carbohydrate Chemistry and Biochemistry Volume 61
293
352
.
J.R. Rich, D. Gehle & M. von Itzstein. 2007. Comprehensive Glycoscience. Comprehensive Glycoscience
885
922
.
Vittorio Farina & Jack D. Brown. (2006) Tamiflu: The Supply Problem. Angewandte Chemie International Edition 45:44, pages 7330-7334.
Crossref
Crossref
Vittorio Farina & Jack D. Brown. (2006) Tamiflu: Das Versorgungsproblem. Angewandte Chemie 118:44, pages 7488-7492.
Crossref
Crossref
Yacine Abed, Mariana Baz & Guy Boivin. (2006) Impact of Neuraminidase Mutations Conferring Influenza Resistance to Neuraminidase Inhibitors in the N1 and N2 Genetic Backgrounds. Antiviral Therapy 11:8, pages 971-976.
Crossref
Crossref
Hui-Ling Yen, Erich Hoffmann, Garry Taylor, Christoph Scholtissek, Arnold S. Monto, Robert G. Webster & Elena A. Govorkova. (2006) Importance of Neuraminidase Active-Site Residues to the Neuraminidase Inhibitor Resistance of Influenza Viruses. Journal of Virology 80:17, pages 8787-8795.
Crossref
Crossref
Andrew G. Watts, Pablo Oppezzo, Stephen G. Withers, Pedro M. Alzari & Alejandro Buschiazzo. (2006) Structural and Kinetic Analysis of Two Covalent Sialosyl-Enzyme Intermediates on Trypanosoma rangeli Sialidase. Journal of Biological Chemistry 281:7, pages 4149-4155.
Crossref
Crossref
Hui-Ling Yen, Louise M. Herlocher, Erich Hoffmann, Mikhail N. Matrosovich, Arnold S. Monto, Robert G. Webster & Elena A. Govorkova. (2005) Neuraminidase Inhibitor-Resistant Influenza Viruses May Differ Substantially in Fitness and Transmissibility. Antimicrobial Agents and Chemotherapy 49:10, pages 4075-4084.
Crossref
Crossref
David Jackson, Wendy Barclay & Thomas Zürcher. (2005) Characterization of recombinant influenza B viruses with key neuraminidase inhibitor resistance mutations. Journal of Antimicrobial Chemotherapy 55:2, pages 162-169.
Crossref
Crossref
Jennifer L McKimm-Breschkin. (2005) Management of Influenza Virus Infections with Neuraminidase Inhibitors. Treatments in Respiratory Medicine 4:2, pages 107-116.
Crossref
Crossref
Yoshihisa Amano & Quan Cheng. (2004) Detection of influenza virus: traditional approaches and development of biosensors. Analytical and Bioanalytical Chemistry 381:1, pages 156-164.
Crossref
Crossref
. 2005. Biochemistry and Molecular Biology of Antimicrobial Drug Action. Biochemistry and Molecular Biology of Antimicrobial Drug Action
107
120
.
Frederick G. Hayden. (2004) Pandemic Influenza. Pediatric Infectious Disease Journal 23:11, pages S262-S269.
Crossref
Crossref
Aeron C Hurt, Jennifer L McKimm-Breschkin, Mandy McDonald, Ian G Barr, Naomi Komadina & Alan W Hampson. (2004) Identification of a human influenza type B strain with reduced sensitivity to neuraminidase inhibitor drugs. Virus Research 103:1-2, pages 205-211.
Crossref
Crossref
Yacine Abed, Nathalie Goyette & Guy Boivin. (2003) A Reverse Genetics Study of Resistance to Neuraminidase Inhibitors in An Influenza A/H1N1 Virus. Antiviral Therapy 9:4, pages 577-581.
Crossref
Crossref
Tomoko Mineno & Marvin J. Miller. (2003) Stereoselective Total Synthesis of Racemic BCX-1812 (RWJ-270201) for the Development of Neuraminidase Inhibitors as Anti-influenza Agents. The Journal of Organic Chemistry 68:17, pages 6591-6596.
Crossref
Crossref